The drug LOY-001, which could extend the lifespan of larger dogs, cleared its first major regulatory hurdle after the FDA found a "reasonable expectation of effectiveness," according to Axios. The San Francisco-based biotech company Loyal for Dogs aims to add at least a year to the lifespans of larger dogs with the long-acting drug, administered every three to six months. Larger dogs typically live between eight and 12 years, while smaller breeds often live much longer.
Related Posts
Artificial intelligence offers hope for better colon cancer detection
It’s one of the most common — and deadliest — cancers in the U.S. According to the Centers for Disease Control and Prevention (CDC), colorectal (colon)…
FDA closes vaping loophole
The Food and Drug Administration (FDA) has closed a loophole that allowed vaping companies to avoid oversight for years, according to CNN. The federal…
Do statins deserve their bad reputation?
People report that statins cause muscle aches and other side effects, but a 2020 study suggests that may be true for only a small percentage of patients….